Evidence map›Paper›PMID 35135041›Full record

GuidelineRevista medica del Instituto Mexicano del Seguro Social2022

[Integrated Care Protocol: Chronic complications of diabetes mellitus 2].

Juan Humberto Medina-Chávez, Manuel Vázquez-Parrodi, Denisse Lizeth Santoyo-Gómez, Jaime Azuela-Antuna, Juan Carlos Garnica-Cuellar, Alejandro Herrera-Landero, Dulce Alejandra Balandrán-Duarte

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. [Neutrophil-lymphocyte ratio and retinopathy in patients with type 2 diabetes mellitus].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Juan Humberto Medina-ChávezInstituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0003-2664-2418
Manuel Vázquez-ParrodiInstituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0002-0833-1088
Denisse Lizeth Santoyo-GómezInstituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Servicio de Endocrinología. Ciudad de México, México.ORCID 0000-0002-3828-7495
Jaime Azuela-AntunaInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 11, Coordinación de Educación e Investigación. Aguascalientes, Aguascalientes, México.ORCID 0000-0002-0588-1973
Juan Carlos Garnica-CuellarInstituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Centro Médico Nacional Hospital "20 de Noviembre", Servicio de Endocrinología. Ciudad de México, México.ORCID 0000-0002-4520-3659
Alejandro Herrera-LanderoInstituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0001-5352-6688
Dulce Alejandra Balandrán-DuarteInstituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0001-9056-1351
Mexican Social Security Institute · MXCentro Médico Nacional La Raza · MXHospital General De Zona · MXInstitute for Social Security and Services for State Workers · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to the International Diabetes Federation, 18% of Mexican adults live with diabetes and it is expected that by 2030 it will occupy the seventh place in the world in number of cases. In the population covered by the Mexican Institute of Social Security, diabetes is the second cause of mortality, years lost due to premature death, years lived with disability and years of healthy life lost, placing it as one of the costliest diseases.

objectiveAddress in a timely and integrated manner chronic complications of type 2 diabetes mellitus, by implementing coordinated actions by multidisciplinary health team in the 3 levels of care. MATERIAL AND

methodsThe process of developing the Integrated Care Protocols consisted of: 1) Prioritization of the health problem, 2) Formation of an interdisciplinary working group, 3) Development of content and systematic search for information 4) Analysis, review and discussion of interventions, 5) Review and validation by regulatory areas, 6) Dissemination and implementation.

conclusionsAdequate glycemic control, blood pressure, lipids and a healthy lifestyle are the key to delaying the presence of micro and macrovascular complications of DM2. However, the progression of the disease will eventually be inevitable, it will confront the health personnel and the patient with some of the complications. In this sense, timely detection and treatment to delay them becomes the main function of the health worker.

Indexed as

Delivery of Health Care, IntegratedDiabetes ComplicationsDiabetes Mellitus, Type 2AdultBlood PressureHumansDiabetes Mellitus, Type 2Diabetic FootHypertensionKidney DiseasesOrganization and Administration

Identifiers

PMID35135041
PMCPMC10396008
OpenAlexW4211266931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.